Piperine
The active compound in black pepper that makes curcumin and other botanical actives actually reach your bloodstream. Mechanism, dosage, safety, and its role in ProleevaMax.
A note from Fabio Lanzieri.
When I was formulating ProleevaMax, the question I came back to most often wasn't which active compounds to include — it was whether those compounds could actually reach circulation in sufficient concentrations to matter. Piperine is my answer to that question. It isn't a headline ingredient. Nobody takes a supplement because the label says "black pepper extract." But remove it from the formula, and the pharmacokinetics of everything next to it changes for the worse. It's the engineering decision that makes the rest of the formula work.
What it is
Piperine is the principal alkaloid in black pepper (Piper nigrum), responsible for the characteristic sharp heat when you crack a peppercorn. Chemically, it is 1-piperoylpiperidine — a simple amide structure that has been studied in pharmacology for decades, long before it became common in supplement formulations. It is also sold in a standardized commercial extract form (BioPerine is the best-known proprietary name), typically standardized to 95% piperine content. The same standardized form — 95% — is what LanFam uses in ProleevaMax1.
How it works
Piperine's primary pharmacological role in a multi-ingredient formula is bioavailability modulation. The short version: piperine inhibits certain Phase II metabolic enzymes — glucuronosyltransferases and sulfotransferases — in both the intestinal wall and the liver. These enzymes normally tag foreign compounds for rapid excretion during what pharmacologists call first-pass metabolism. When you swallow curcumin without piperine, much of it is conjugated within minutes and swept out of your system before it can reach systemic circulation at useful concentrations. Piperine slows that conjugation process, giving co-administered compounds a longer window to be absorbed through the intestinal wall and distributed through the bloodstream2.
The landmark demonstration of this mechanism is Shoba and colleagues' 1998 human pharmacokinetic study. They measured curcumin serum concentrations in healthy volunteers given curcumin alone versus curcumin co-administered with 20 mg piperine. The piperine co-administration group showed a 2,000% increase in curcumin bioavailability — serum curcumin was measurable and sustained at levels that were essentially undetectable in the curcumin-only group3. That finding has been replicated in animal models and cross-validated with other polyphenols, though the human data for curcumin remains the most cited2.
Beyond its adjuvant role, piperine has documented direct pharmacological activity. It modulates thermogenin expression in brown adipose tissue, interacts with TRPV1 channels involved in pain signaling, and has shown some NF-κB suppression in cell-culture models4. These secondary effects are real but modest relative to its delivery function — piperine earns its place in the formula primarily as an absorption adjuvant, not as an independent anti-inflammatory agent1.
The evidence
The bioavailability story is unusually well-supported for a single compound. The Shoba 1998 paper — a peer-reviewed human pharmacokinetic trial in Planta Medica — remains the keystone citation more than 25 years after publication3. A comprehensive 2022 pharmacological review in the Beni Suef University Journal of Basic and Applied Sciences catalogued piperine's full activity profile across membrane permeability effects, enzyme modulation, and secondary signaling pathways, confirming the bioavailability mechanism and characterizing the secondary anti-inflammatory surface1. Earlier mechanistic work by Atal and colleagues (1985) documented the thermogenic and enzyme-inhibition effects that underlie the bioavailability finding, providing the foundational pharmacology that Shoba 1998 built upon5. Khajuria and colleagues (1998) confirmed that piperine increases intestinal epithelial permeability directly, adding a second mechanism — alongside Phase II enzyme inhibition — through which absorption of co-administered compounds is improved6.
Pharmacological aspects of piperine: a comprehensive review
Tripathi AK, Kohli S — Beni Suef Univ J Basic Appl Sci · 2022
Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4
Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF — J Pharmacol Exp Ther · 2002
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers
Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivasan PS — Planta Med · 1998
Piperine — A major principle of black pepper: A review of its bioactivity and studies
Stojanović-Radić Z, Pejčić M, Dimitrijević M, et al — Appl Sci · 2019
Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism
Atal CK, Dubey RK, Singh J — J Pharmacol Exp Ther · 1985
Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics
Khajuria A, Thusu N, Zutshi U — Phytomedicine · 2002
Dosage
Supplement studies typically use 5-20 mg/day of standardized piperine extract, co-administered with other actives rather than taken alone. The Shoba 1998 bioavailability trial used 20 mg. Lower doses (5-10 mg) are standard in commercial curcumin formulations and produce meaningful bioavailability effects. Consult your physician before starting daily supplementation, particularly if you take prescription medications (see interactions below).
Safety & interactions
At supplement doses (5-20 mg/day), piperine is well-tolerated for most adults. The primary caution is pharmacokinetic, not toxic: piperine's CYP3A4 modulation — the same mechanism that makes it useful for bioavailability — creates a meaningful drug-interaction surface2. CYP3A4 is the liver enzyme responsible for metabolizing a wide range of prescription drugs, including:
- Statins (atorvastatin, simvastatin, lovastatin) — piperine can raise plasma concentrations
- Calcium-channel blockers (amlodipine, nifedipine) — similar interaction potential
- Some antidepressants (certain SSRIs, tricyclics) — slower metabolism, altered steady-state levels
- Immunosuppressants (cyclosporine, tacrolimus) — narrow therapeutic index; interaction risk is clinically significant
If you take prescription medication metabolized by CYP3A4, talk to your physician before adding piperine to your daily routine. The interaction surface is not theoretical — it is the same mechanism that makes piperine a useful bioavailability adjuvant in the first place.
Pregnancy and lactation: food-level black pepper is widely consumed safely; high-dose standardized piperine extract has not been adequately studied in pregnant or nursing women and should be avoided unless cleared by your physician.
In ProleevaMax
Piperine occupies Pathway 3 — Absorption & Delivery — in the ProleevaMax formula. Its job is to ensure the other 12 actives, particularly curcumin and boswellia serrata, reach systemic circulation at concentrations where the clinical evidence for those compounds actually applies. We use the 95% standardized form at a dose consistent with the Shoba pharmacokinetic literature. Without Pathway 3, Pathways 1 and 2 would be operating on assumptions the trial data doesn't support.*
Frequently asked questions
Piperine is the shortest story in ProleevaMax's ingredient list, but it's not a minor one. It's the reason a careful formulation outperforms a careless one using the same headline actives. The chemistry of oral bioavailability doesn't forgive the omission.
— Fabio
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
— Fabio Lanzieri, Co-founder & CEO
Co-founder & CEO
Fabio Lanzieri spent 40 years inside the pharmaceutical industry before founding LanFam Health with his wife Maria and daughter Cristina. When Maria's breast-cancer recovery left her dependent on estrogen-blocking medication and chronic pain that doctors could only address with daily NSAIDs, Fabio went looking for an alternative. Pharma didn't have one. Non-pharma didn't address root cause.
So he built one — at their kitchen table. The result became ProleevaMax, a synergistic formulation targeting six inflammatory pathways with 13 standardized ingredients. Every formulation decision still passes Fabio's family standard: if we wouldn't give it to our own, we won't make it.
Fabio's writing covers the mechanism science behind chronic inflammation — NF-κB, COX-2, NLRP3, the gut-brain axis, and how individual compounds modulate them. He writes the way he explains things at the dinner table: warmth first, then the science.
What Fabio writes about
- Chronic inflammation as a root cause across joint pain, neuroinflammation, metabolic dysfunction, and aging
- The 6-pathway framework — how inflammation goes from acute and protective to chronic and corrosive
- Individual compounds (curcumin, boswellia, resveratrol, panax ginseng, L-glutamine) and how they modulate inflammatory pathways
- NSAID alternatives — what 40 years of pharmaceutical research has and hasn't proven about long-term use
There's a seat at our table
Letters from our family to yours — the science, the recipes, the things that actually helped real families. Leave your email and we'll send the next one.
